Balance Sheet
Cash Flow Statement
AmortizationAmortizationCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Change in Cash (2016 - 2025)

MediWound has reported Change in Cash over the past 13 years, most recently at -$27.9 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 1142.46% year-over-year to -$27.9 million; the TTM value through Dec 2025 reached -$4.4 million, down 60.68%, while the annual FY2025 figure was -$4.4 million, 60.68% down from the prior year.
  • Change in Cash for Q4 2025 was -$27.9 million at MediWound, down from $31.7 million in the prior quarter.
  • Over five years, Change in Cash peaked at $31.7 million in Q3 2025 and troughed at -$31.9 million in Q2 2023.
  • A 5-year average of -$364000.0 and a median of -$495500.0 in 2021 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: tumbled 1191.17% in 2022 and later skyrocketed 1079.81% in 2025.
  • Year by year, Change in Cash stood at -$2.6 million in 2021, then skyrocketed by 820.14% to $19.0 million in 2022, then tumbled by 86.38% to $2.6 million in 2023, then grew by 3.59% to $2.7 million in 2024, then crashed by 1142.46% to -$27.9 million in 2025.
  • Business Quant data shows Change in Cash for MDWD at -$27.9 million in Q4 2025, $31.7 million in Q3 2025, and -$300000.0 in Q2 2025.